AlphaFold-powered protein redesign aims for safer gene editing while Twist Bioscience stock drops

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience slides 5.03% today

Highlights

TWST is trading below key short-term moving averages, signaling pronounced short-term downward pressure amid heightened volatility.
The stock has declined over 5% in today's session and now trades at the lower end of its weekly range.
Expected range for next week is $82.00–$95.00, with a high probability of a sideways or upward move unless support breaks below $82.00.

Further information is available at the provided link.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Short-term downside as price slips below key moving averages

TWST is currently trading at $85.73, below both the SMA-20 ($94.40) and Ichimoku Kijun ($93.48), with the SMA-50 ($79.75) acting as near-term support and the SMA-200 ($51.15) reinforcing long-term bullish structure. This setup signals short-term downward pressure, medium-term support above major weekly averages, and immediate resistance at the Kijun level.

Mixed momentum signals as pronounced selling drives weekly lows

Momentum signals on D1 are mixed, with MACD showing strong buy and ADX indicating a bullish trend, yet Stoch RSI and CCI both flag oversold conditions. BBP points to a recent shift toward seller dominance, while the AO remains neutral. TWST has fallen $4.54 (5.05%) from last week’s close at $90.27, now sitting at the very bottom of its weekly range, which highlights pronounced selling pressure as volatility stands at 14.38%. In today’s session, the stock is down over 5%, deepening its weekly slide and marking a steady decline from earlier highs.

High upside probability as consolidation forms within new range

Looking ahead, the expected weekly trading range is adjusted realistically to $82.00–$95.00, bracketing TWST’s current level and fitting within historical volatility. The up probability for next week is very high (more than 80%) based on consistently bullish signals from W1 RSI, ADX, MACD, and MA-50, making a downside reversal much less likely. The baseline scenario favors sideway movement within this corridor. A bullish breakout would require clearing resistance near $93.50 (Kijun/SMA-20), opening room toward $95.00. A bearish move below $82.00 could expose the SMA-50 ($79.75) as next support. The forecast range keeps price well above the 52-week low ($23.30) but below the recent annual high ($105.41), reflecting ongoing consolidation after a period of strong year-to-date gains.

Previously it was reported that Twist Bioscience was exhibiting a strong bullish trend with momentum indicators signaling a potential breakout or reversal, making key technical levels critical for traders. This article builds on that outlook by emphasizing the importance of closely monitoring immediate resistance and support zones, as the next decisive move in the stock's trajectory will likely be led by a clear breach of these thresholds.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.